Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.95M Buy
5,506
+528
+11% +$188K 0.02% 138
2025
Q4
$1.63M Buy
4,978
+1,788
+56% +$567K 0.02% 144
2025
Q3
$897K Buy
+3,190
New +$925K 0.01% 175
2024
Q4
Sell
-8,834
Closed -$2.82M 160
2024
Q3
$2.82M Buy
8,834
+6,636
+302% +$2.17M 0.04% 102
2024
Q2
$694K Sell
2,198
-130
-6% -$38.2K 0.01% 124
2024
Q1
$663K Hold
2,328
0.01% 125
2023
Q4
$674K Sell
2,328
-36
-2% -$9.81K 0.01% 127
2023
Q3
$635K Sell
2,364
-184
-7% -$45.9K 0.01% 120
2023
Q2
$569K Sell
2,548
-426
-14% -$98.8K 0.01% 123
2023
Q1
$719K Buy
+2,974
New +$730K 0.02% 110

Other funds holding AMGN

ABN AMRO Bank's AMGN Position: Q1 2026 in Review

ABN AMRO Bank increased its Amgen (AMGN) stake by 11% in Q1 2026, buying an estimated $188K and bringing the position to 5,506 shares worth $1.95M. The position accounts for 0.02% of the portfolio, ranked #138.

ABN AMRO Bank first reported a position in AMGN in Q1 2023 and has held it in 10 quarters since. The position peaked at $2.82M in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • ABN AMRO Bank held 5,506 shares of Amgen worth $1.95M as of Q1 2026.
  • ABN AMRO Bank bought 528 Amgen shares in Q1 2026, an estimated $188K.
  • Amgen made up 0.02% of ABN AMRO Bank's portfolio in Q1 2026, its #138 holding.
  • ABN AMRO Bank first reported a position in Amgen in Q1 2023 and has held it in 10 quarters since.
  • ABN AMRO Bank's Amgen position peaked at $2.82M in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on ABN AMRO Bank's 13F filing for Q1 2026, filed 22 Apr 2026.